{"id":4266,"date":"2026-03-05T12:28:11","date_gmt":"2026-03-05T12:28:11","guid":{"rendered":"https:\/\/navia.co.in\/blog\/?p=4266"},"modified":"2026-03-05T12:28:12","modified_gmt":"2026-03-05T12:28:12","slug":"pharmabees-etf","status":"publish","type":"post","link":"https:\/\/navia.co.in\/blog\/pharmabees-etf\/","title":{"rendered":"Understanding Pharmabees ETF: An Overview of Healthcare Sector Exposure"},"content":{"rendered":"<ul><li><a class=\"aioseo-toc-item\" href=\"#what-is-pharmabees-etf\">Why Invest in PHARMABEES ETF?<\/a><\/li><li><a class=\"aioseo-toc-item\" href=\"#top-companies-in-the-pharmabees-etf\">Performance Overview<\/a><\/li><li><a class=\"aioseo-toc-item\" href=\"#top-holdings\">Top Holdings<\/a><\/li><li><a class=\"aioseo-toc-item\" href=\"#how-to-invest-in-pharmabees-etf\">Advantages of Investing in PHARMABEES ETF<\/a><ul><\/ul><\/li><li><a class=\"aioseo-toc-item\" href=\"#invest-in-pharmabees-etf-through-the-navia-app\">Is PHARMABEES Right for You?<\/a><\/li><li><a class=\"aioseo-toc-item\" href=\"#why-choose-navias-zero-brokerage-stock-investing-app-to-invest-in-pharmabees-etf\">Why Choose Navia\u2019s Zero Brokerage Stock Investing App to invest in PHARMABEES ETF?<\/a><\/li><li><a class=\"aioseo-toc-item\" href=\"#here-is-a-list-of-other-pharma-et-fs-and-their-returns-as-on-28th-september-2024\">List of Other PHARMA ETF\u2019s And Their Historical Performance<\/a><\/li><li><a class=\"aioseo-toc-item\" href=\"#steps-to-set-up-sip-for-bank-bees-etf-on-navia-app\">How to Invest in PHARMABEES ETF on Navia APP?<\/a><\/li><li><a class=\"aioseo-toc-item\" href=\"#conclusion\">Conclusion<\/a><\/li><li><a class=\"aioseo-toc-item\" href=\"#aioseo-frequently-asked-questions-49\">Frequently Asked Questions<\/a><\/li><\/ul>\n\n\n<p>Recent global shifts have underscored the indispensable nature of the healthcare and pharmaceutical sectors, making them more vital than ever. For individuals seeking exposure to the healthcare and pharmaceutical sector, the Nippon India Nifty Pharma ETF (<strong><a href=\"https:\/\/navia.co.in\/ETF\/nippon-india-nifty-pharma-etf\/\" title=\"\">PHARMABEES ETF<\/a><\/strong>) provides a strategic entry point. This ETF offers diversified exposure to India\u2019s top pharmaceutical firms, providing exposure to developments in the pharmaceutical and healthcare industry.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-7846cf486ec21e69662daa52acece04a\" id=\"what-is-pharmabees-etf\" style=\"color:#023368\">Why Invest in PHARMABEES ETF?\u00a0<\/h2>\n\n\n\n<p>The <a href=\"https:\/\/navia.co.in\/ETF\/nippon-india-nifty-pharma-etf\/\" title=\"\"><strong>PHARMABEES ETF<\/strong><\/a> offers a streamlined way to track the Nifty Pharma Index, providing exposure to leading players in the pharmaceutical industry. By investing in this ETF, investors gain exposure to the healthcare sector represented in the index and the ongoing advancements in medical research and manufacturing.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-f905937364f832bf114d884fa4795260\" id=\"top-companies-in-the-pharmabees-etf\" style=\"color:#023368\">Performance Overview<\/h2>\n\n\n\n<p>The <strong>PHARMABEES ETF<\/strong> has reflected the movement of the underlying index, mirroring the movement aligned with the sector&#8217;s historical trends of the pharmaceutical industry. The following data provides a clear comparison of the fund\u2019s performance against both its benchmark and the broader category:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Time Period<\/th><th>Fund Returns (%)<\/th><th>Category Returns (%)<\/th><\/tr><\/thead><tbody><tr><td>6 Months&nbsp;<\/td><td>3.22&nbsp;<\/td><td>3.82&nbsp;<\/td><\/tr><tr><td>1 Year&nbsp;<\/td><td>14.40&nbsp;<\/td><td>17.03&nbsp;<\/td><\/tr><tr><td>3 Years&nbsp;<\/td><td>24.85&nbsp;<\/td><td>17.97&nbsp;<\/td><\/tr><tr><td>Since Inception&nbsp;&nbsp;&nbsp;<\/td><td>11.26&nbsp;<\/td><td>&#8211;&nbsp;<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Mirroring the Nifty Pharma Index&#8217;s trajectory, the <strong>PHARMABEES ETF<\/strong> has demonstrated a historical performance reflecting the index movement. Its performance underscores a precise alignment with the pharmaceutical sector&#8217;s expansion, establishing it as an ETF designed to track the pharmaceutical sector index. <\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-b6a867c80d4184bbb288e46468398f04\" id=\"top-holdings\" style=\"color:#023368\">Top Holdings<\/h2>\n\n\n\n<p>The <strong>PHARMABEES ETF <\/strong>maintains a concentrated exposure to the leaders of India&#8217;s healthcare sector. The fund&#8217;s primary allocations are dominated by several of the largest and most influential pharmaceutical companies in the country:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Company<\/th><th>Sector<\/th><th>% of Total Holdings<\/th><\/tr><\/thead><tbody><tr><td>Sun Pharmaceutical Industries Ltd&nbsp;<\/td><td>Pharmaceuticals&nbsp;<\/td><td>21.29%&nbsp;<\/td><\/tr><tr><td>Divi\u2019s Laboratories Ltd&nbsp;<\/td><td>Pharmaceuticals&nbsp;<\/td><td>9.69%&nbsp;<\/td><\/tr><tr><td>Cipla Ltd&nbsp;<\/td><td>Pharmaceuticals&nbsp;<\/td><td>9.39%&nbsp;<\/td><\/tr><tr><td>Dr. Reddy\u2019s Laboratories Ltd&nbsp;<\/td><td>Pharmaceuticals&nbsp;<\/td><td>9.36%&nbsp;&nbsp;<\/td><\/tr><tr><td>Lupin Ltd&nbsp;<\/td><td>Pharmaceuticals&nbsp;<\/td><td>6.58%&nbsp;<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-3d2884031bc31cc4deedd99507395d97\" id=\"how-to-invest-in-pharmabees-etf\" style=\"color:#023368\">Advantages of Investing in PHARMABEES ETF<\/h2>\n\n\n\n<h3 class=\"wp-block-heading has-text-color has-link-color wp-elements-ea10e0666a6c498bbb150f17d6d10d5a\" id=\"aioseo-sectoral-diversification-12\" style=\"color:#ec4d37\">Sectoral Diversification\u00a0<\/h3>\n\n\n\n<p>Instead of betting on a single pharma company; where a failed clinical trial or a regulatory audit could crash into the stock, <strong>PHARMABEES <\/strong>gives you a basket of the top 20 pharmaceutical companies. This minimizes &#8220;unsystematic risk&#8221; and provides exposure to the broader healthcare sector represented in the index.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-color has-link-color wp-elements-f253ed8feeb056ba33b1d7077622496c\" id=\"aioseo-cost-efficiency-14\" style=\"color:#ec4d37\">Cost Efficiency\u00a0<\/h3>\n\n\n\n<p>Managing a portfolio of 20 stocks involves significant brokerage and transaction costs. Since <strong>PHARMABEES <\/strong>is an <strong>ETF<\/strong>, it has a much lower Expense Ratio compared to actively managed pharma mutual funds.\u00a0Lower costs may help investors reduce overall investment expenses over time.\u00a0<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-color has-link-color wp-elements-eaff8a08ef2dc451509d5668965291f5\" id=\"aioseo-hedging-against-market-volatility-16\" style=\"color:#ec4d37\">Hedging Against Market Volatility\u00a0<\/h3>\n\n\n\n<p>The pharmaceutical sector is traditionally considered a defensive sector. In a slowing economy or a bear market, people still need medicine and healthcare. Consequently, pharmaceutical companies are sometimes categorized as part of defensive sectors due to the essential nature of healthcare services.\u00a0<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-color has-link-color wp-elements-7db38129dc607bd84db3f5524e597dd6\" id=\"aioseo-high-liquidity-and-transparency-18\" style=\"color:#ec4d37\">High Liquidity and Transparency\u00a0<\/h3>\n\n\n\n<p>Because it is traded on the <strong><a href=\"https:\/\/www.nseindia.com\/\" title=\"\">NSE<\/a> <\/strong>like a regular stock, you can buy or sell units of\u00a0<strong>PHARMABEES\u00a0<\/strong>at any time during market hours. The underlying holdings are published daily, providing a level of transparency that allows you to know exactly what you own.\u00a0<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-color has-link-color wp-elements-01b72e1604a32571733733d9476e5200\" id=\"aioseo-exposure-to-the-global-pharmacy-theme-20\" style=\"color:#ec4d37\">Exposure to the &#8220;Global Pharmacy&#8221; Theme\u00a0<\/h3>\n\n\n\n<p>Indian pharmaceutical companies are major suppliers of generic drugs and vaccines worldwide. By investing in this ETF, you are tapping into India\u2019s competitive advantage in global healthcare manufacturing and R&amp;D.\u00a0<\/p>\n\n\n\n<a href=\"https:\/\/open.navia.co.in\/index-navia.php?utm_source=organic&#038;utm_medium=blog\" target=\"_blank\" style=\"display:flex; width:100%;\" ><img decoding=\"async\" src=\"https:\/\/d1l8l3rp33cdzs.cloudfront.net\/images\/naviacee\/Open-free-demat-account%20%28blog%29%20%281%29.gif\" width=\"80%\" \nheight=\"auto\"  style=\"border-radius:10px; margin:5px auto;\"\/><\/a>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-34685b4bfaca34874d52bcfb06ed7615\" id=\"invest-in-pharmabees-etf-through-the-navia-app\" style=\"color:#023368\">Is PHARMABEES Right for You?\u00a0<\/h2>\n\n\n\n<p>For individuals seeking sector-specific exposure to healthcare, the <strong>PHARMABEES ETF<\/strong> serves as a sector-focused exchange-traded fund. By combining sector growth trends with broad diversification and low-cost efficiency, it offers a versatile solution for long-term investors with varying investment approaches from shifting healthcare trends.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-58378b215fa06d505f3c55f37396b3fc\" id=\"why-choose-navias-zero-brokerage-stock-investing-app-to-invest-in-pharmabees-etf\" style=\"color:#023368\">Why Choose Navia\u2019s Zero Brokerage Stock Investing App to invest in PHARMABEES ETF?\u202f<\/h2>\n\n\n\n<p>Choosing <strong>PHARMABEES ETF<\/strong> via Navia\u2019s platform provides a powerful combination of sector-specific growth and cost-efficiency. The zero-brokerage structure may help reduce transaction costs for investors.<\/p>\n\n\n\n<p>\ud83d\udd38\u202f <strong>Cost Savings:<\/strong> <a href=\"https:\/\/navia.co.in\/\" title=\"\">Zero brokerage<\/a> ensures that investors save on transaction costs, helping lower trading costs.<\/p>\n\n\n\n<p>\ud83d\udd38 \u202f<strong>User-Friendly Interface: <\/strong>Navia\u2019s app is designed to be intuitive and easy to use, making the <a href=\"https:\/\/navia.co.in\/blog\/category\/investments\/\" title=\"\">investment<\/a> process seamless.\u202f<\/p>\n\n\n\n<p>\ud83d\udd38 \u202f<strong>Easy Stock\/ETF SIP Baskets: <\/strong>Easily create a stock\/<strong><a href=\"https:\/\/navia.co.in\/blog\/grow-your-wealth-with-navia-readymade-etf-baskets\/\" title=\"\">ETF basket<\/a><\/strong> of your choice and start an <a href=\"https:\/\/navia.co.in\/mutual-funds\" title=\"\"><strong>SIP<\/strong><\/a>.<\/p>\n\n\n\n<p>\ud83d\udd38\u202f <strong>24\/7 Accessibility: <\/strong>Investors can manage their investments anytime, anywhere, providing convenience and flexibility.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-69e9043635719fcbbf5eb1afe8a41686\" id=\"here-is-a-list-of-other-pharma-et-fs-and-their-returns-as-on-28th-september-2024\" style=\"color:#023368\">List of Other PHARMA ETF\u2019s And Their Historical Performance<\/h2>\n\n\n\n<p>Note: As on 27 February 2026\u00a0<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>ETF Name<\/th><th>30 Day Return<\/th><th>365 Day Return<\/th><\/tr><\/thead><tbody><tr><td>PHARMABEES&nbsp;<\/td><td>5.81%&nbsp;<\/td><td>11.08%&nbsp;<\/td><\/tr><tr><td>MOHEALTH (Motilal Oswal S&amp;P BSE Healthcare ETF)&nbsp;<\/td><td>6.91%&nbsp;<\/td><td>11.83%&nbsp;<\/td><\/tr><tr><td>HEALTHADD (DSP Nifty Healthcare ETF)&nbsp;<\/td><td>7.20%&nbsp;<\/td><td>14.43%&nbsp;<\/td><\/tr><tr><td>HEALTHY&nbsp;(Aditya Birla Sun Life Nifty Healthcare ETF)&nbsp;<\/td><td>7.20%&nbsp;<\/td><td>14.33%&nbsp;<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-8deaa64ec4253bbc4f9ea45cbe502376\" id=\"steps-to-set-up-sip-for-bank-bees-etf-on-navia-app\" style=\"color:#023368\">How to Invest in PHARMABEES ETF on Navia APP?<\/h2>\n\n\n\n<p>1.&nbsp;Download and&nbsp;Log&nbsp;in&nbsp;to the Navia app.&nbsp;<\/p>\n\n\n\n<p>2. Go to <strong>Tools->Basket<\/strong> and create a Basket with\u00a0name\u00a0of your choice. After creating the basket name, click on the <strong>Proceed to Add Items<\/strong> button.\u00a0<\/p>\n\n\n\n<p>3. It opens a page there you can add <strong>PHARMABEES <\/strong>to the basket and select the quantity and price. Then click on the Add Symbol option. Market price is most preferable if you are\u00a0setting up\u00a0a SIP.\u00a0<\/p>\n\n\n\n<p>4. After adding it to\u00a0Basket,\u00a0click on the <strong>SIP Order<\/strong> option to confirm and Activate the SIP.\u00a0<\/p>\n\n\n\n<p>5. Enter <strong>Frequency, Installment and Weekly SIP Day<\/strong>, then agree to the <strong>Terms &amp;\u00a0Conditions<\/strong>,\u00a0then click on the <strong>Activate SIP<\/strong> option.\u00a0<\/p>\n\n\n\n<p>6. You can always <strong>Pause<\/strong> the SIP when needed. You can also edit the <strong>Stock Price and QTY<\/strong> in the SIP by using the <strong>Edit<\/strong> option.\u00a0<\/p>\n\n\n\n<p>With <strong><a href=\"https:\/\/navia.co.in\/\" title=\"\">zero brokerage<\/a><\/strong>, setting up a SIP on the Navia app is cost-effective and hassle-free, making it an excellent\u00a0option\u00a0for long-term investors. Navia also provides FREE Ready-made <a href=\"https:\/\/navia.co.in\/blog\/grow-your-wealth-with-navia-readymade-etf-baskets\/\" title=\"\"><strong>ETF basket<\/strong><\/a> for hassle-free SIP investment on selected TOP\u00a0ETF\u2019s.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-f7a256d16fc072598f5a6ddca001bcff\" id=\"conclusion\" style=\"color:#023466\">Conclusion<\/h2>\n\n\n\n<p>The <strong>Nippon India Nifty Pharma ETF (<a href=\"https:\/\/navia.co.in\/ETF\/nippon-india-nifty-pharma-etf\/\" title=\"\">PHARMABEES <strong>ETF<\/strong><\/a>) <\/strong>provides an exposure to companies within India\u2019s healthcare sector. By tracking top-tier pharmaceutical companies, this ETF offers a balance of historical performance based on available market data and targeted sector exposure, making it an one of the available investment instruments for those looking to gain exposure to India\u2019s pharmaceutical manufacturing sector.<\/p>\n\n\n\n<p>Securing a position in this resilient industry allows you to participate in a sector driven by consistent global and domestic demand. By integrating <strong>PHARMABEES <\/strong>into your portfolio today, you can align your long-term financial goals with the growth of one of India&#8217;s most innovative sectors.<\/p>\n\n\n\n<p>Explore the\u00a0<strong>PHARMABEES ETF<\/strong>\u00a0and investors may explore this ETF after evaluating their investment objectives!\u00a0<\/p>\n\n\n\n<p class=\"has-text-align-center\"><strong>Do You Find This Interesting?<\/strong><\/p>\n\n\n\n<div class=\"wp-block-group is-nowrap is-layout-flex wp-container-core-group-is-layout-ad2f72ca wp-block-group-is-layout-flex\">\n<p>We\u2019d Love to Hear from you-<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/form.typeform.com\/to\/bpQ8ZlDc\"><img decoding=\"async\" width=\"300\" height=\"64\" src=\"https:\/\/navia.co.in\/blog\/wp-content\/uploads\/2025\/02\/Yes-No-Button-1.png\" alt=\"feedback yes or no button\" class=\"wp-image-8901\" srcset=\"https:\/\/navia.co.in\/blog\/wp-content\/uploads\/2025\/02\/Yes-No-Button-1.png 300w, https:\/\/navia.co.in\/blog\/wp-content\/uploads\/2025\/02\/Yes-No-Button-1-150x32.png 150w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/figure>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-87d42fde2844e469ff52c5b9555a10de\" id=\"aioseo-frequently-asked-questions-49\" style=\"color:#023368\">Frequently Asked Questions\u00a0<\/h2>\n\n\n<div class=\"wp-block-ub-content-toggle wp-block-ub-content-toggle-block\" id=\"ub-content-toggle-block-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" data-mobilecollapse=\"true\" data-desktopcollapse=\"true\" data-preventcollapse=\"false\" data-showonlyone=\"false\">\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1; \" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-0-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" style=\"color: #000000; \"><strong>Is\u00a0Pharmabees\u00a0a good investment?<\/strong>\u00a0<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-0-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\">\n\n<p>The <strong>Nippon India Nifty Pharma ETF (<a href=\"https:\/\/navia.co.in\/ETF\/nippon-india-nifty-pharma-etf\/\" title=\"\">PHARMABEES ETF<\/a>)<\/strong> serves as a an option for gaining sector exposure aiming to tap into the evolving healthcare landscape. By combining\u00a0a track record\u00a0of historical performance based on market data with a portfolio of high-conviction holdings, this ETF provides a streamlined, sector-focused vehicle to provide exposure to long-term sector trends of India&#8217;s pharmaceutical industry.\u00a0<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1; \" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-1-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" style=\"color: #000000; \"><strong>Is pharma ETF\u00a0a good investment?<\/strong>\u00a0<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-1-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\">\n\n<p>While a pharma ETF provides a cost-efficient gateway to India\u2019s healthcare giants, its performance is closely tied to shifting industry trends, regulatory hurdles, and global export demand. Investors should note that because this is a thematic fund, it carries higher concentration risk and susceptibility to policy changes compared to diversified indices.\u00a0<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1; \" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-2-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" style=\"color: #000000; \"><strong>What is the purpose of\u00a0pharmabees?<\/strong>\u00a0<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-2-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\">\n\n<p>The Nippon India Nifty Pharma ETF is designed to provide investors with a streamlined, cost-effective way to capture the performance of the entire pharmaceutical industry through one diversified asset.\u00a0<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1; \" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-3-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" style=\"color: #000000; \"><strong>What are the risks of investing in pharma ETFs?<\/strong>\u00a0<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-3-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\">\n\n<p><strong>Regulatory Roadblocks: <\/strong>Stringent industry oversight means that drug application rejections or policy shifts can instantly devalue specific holdings and the overall ETF.\u00a0<\/p>\n\n\n\n<p><strong>Clinical trial risk:\u00a0<\/strong>The sector depends on R&amp;D success; if a key drug\u00a0fails to\u00a0meet its primary endpoints during trials, the resulting stock price crash will drag down ETF performance.\u00a0\u00a0<\/p>\n\n\n\n<p><strong>Patent cliff risk:\u00a0<\/strong>When patents on blockbuster drugs expire, generic competition floods the market, leading to sharp revenue declines for major companies within the fund.\u00a0<\/p>\n\n\n\n<p><strong>Concentration risk:\u00a0<\/strong>Despite being a basket of stocks, these ETFs are\u00a0sector specific. If the fund is heavily weighted toward a few giant firms, their individual setbacks will disproportionately\u00a0impact\u00a0your returns.\u00a0<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1; \" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-4-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\" style=\"color: #000000; \"><strong>Are ETFs riskier than stocks?<\/strong>\u00a0<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-4-f48e8e58-73aa-4871-8b3b-56bdc3b9b433\">\n\n<p>Exchange-traded funds (ETFs)\u00a0generally offer\u00a0a lower risk profile than individual securities by providing immediate, built-in diversification. To\u00a0optimize\u00a0a portfolio, you can use a &#8220;core and satellite&#8221; approach:\u00a0utilize\u00a0ETFs to stabilize your foundation through broad market exposure, while strategically adding individual stocks and bonds to chase higher potential returns or specific income goals.\u00a0<\/p>\n\n<\/div>\n\t\t<\/div>\n<\/div>\n\n\n<p><strong>DISCLAIMER: Investments in the securities market are subject to market risks, read all the related documents carefully before investing. The securities quoted are exemplary and are not recommendatory. Brokerage will not exceed the SEBI prescribed limit<\/strong>.<a href=\"https:\/\/telegram.me\/share\/url?url=https%3A%2F%2Fnavia.co.in%2Fblog%2Fturtle-trading%2F&amp;text=Turtle%20Trading%20Experiment%3A%20Can%20You%20Be%20Trained%20to%20Master%20the%20Markets%3F%C2%A0\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https%3A%2F%2Fnavia.co.in%2Fblog%2Fimplied-volatility-in-options%2F\" rel=\"noreferrer noopener\" target=\"_blank\"><\/a><a href=\"https:\/\/twitter.com\/intent\/tweet?text=Mastering%20the%20Invisible%20Force%3A%20A%20Guide%20to%20Implied%20Volatility%20in%20Options%20Trading&amp;url=https%3A%2F%2Fnavia.co.in%2Fblog%2Fimplied-volatility-in-options%2F\" rel=\"noreferrer noopener\" target=\"_blank\"><\/a><a href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https%3A%2F%2Fnavia.co.in%2Fblog%2Fimplied-volatility-in-options%2F\" rel=\"noreferrer noopener\" target=\"_blank\"><\/a><a href=\"https:\/\/api.whatsapp.com\/send?text=Mastering%20the%20Invisible%20Force%3A%20A%20Guide%20to%20Implied%20Volatility%20in%20Options%20Trading%20https%3A%2F%2Fnavia.co.in%2Fblog%2Fimplied-volatility-in-options%2F\" rel=\"noreferrer noopener\" target=\"_blank\"><\/a><a href=\"https:\/\/telegram.me\/share\/url?url=https%3A%2F%2Fnavia.co.in%2Fblog%2Fimplied-volatility-in-options%2F&amp;text=Mastering%20the%20Invisible%20Force%3A%20A%20Guide%20to%20Implied%20Volatility%20in%20Options%20Trading\" rel=\"noreferrer noopener\" target=\"_blank\"><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recent global shifts have underscored the indispensable nature of the healthcare and pharmaceutical sectors, making them more vital than ever. For individuals seeking exposure to the healthcare and pharmaceutical sector, the Nippon India Nifty Pharma ETF (PHARMABEES ETF) provides a strategic entry point. This ETF offers diversified exposure to India\u2019s top pharmaceutical firms, providing exposure [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":16373,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[12,255,7,21,256,32],"class_list":["post-4266","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-etf-strategies","tag-etfs","tag-healthcare","tag-indian-stock-markets","tag-investments","tag-pharmabees-etf","tag-wealth-creation"],"featured_image_src":"https:\/\/navia.co.in\/blog\/wp-content\/uploads\/2024\/08\/UnderstandingPharmabeesETF-bloghea.jpeg","author_info":{"display_name":"Navia Markets","author_link":"https:\/\/navia.co.in\/blog\/author\/tradeplusonline\/"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/posts\/4266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/comments?post=4266"}],"version-history":[{"count":40,"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/posts\/4266\/revisions"}],"predecessor-version":[{"id":16382,"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/posts\/4266\/revisions\/16382"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/media\/16373"}],"wp:attachment":[{"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/media?parent=4266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/categories?post=4266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/navia.co.in\/blog\/wp-json\/wp\/v2\/tags?post=4266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}